The role of CD95 and CD95 ligand in cancer.
作者信息
Peter M E, Hadji A, Murmann A E, Brockway S, Putzbach W, Pattanayak A, Ceppi P
出版信息
Cell Death Differ. 2015 May;22(5):885-6. doi: 10.1038/cdd.2015.25.
Abstract
摘要
相似文献
1
The role of CD95 and CD95 ligand in cancer.CD95和CD95配体在癌症中的作用。
Cell Death Differ. 2015 May;22(5):885-6. doi: 10.1038/cdd.2015.25.
2
Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells.CD95（Fas/APO-1）受体/配体系统在野生型p53基因转导诱导人癌细胞凋亡中的差异作用。
Oncogene. 1999 Apr 1;18(13):2189-99. doi: 10.1038/sj.onc.1202561.
3
CD95 ligand expression in dedifferentiated breast cancer.去分化乳腺癌中CD95配体的表达
J Pathol. 1999 Nov;189(3):378-86. doi: 10.1002/(SICI)1096-9896(199911)189:3<378::AID-PATH439>3.0.CO;2-D.
4
Characterisation of the roles of CD95 and CD95 ligand in cord blood.CD95和CD95配体在脐带血中的作用特征
Bone Marrow Transplant. 1998 Jul;22 Suppl 1:S44-7.
5
Regulation of CD95 (Fas) ligand expression by TCR-mediated signaling events.TCR介导的信号事件对CD95（Fas）配体表达的调控。
J Immunol. 1997 May 15;158(10):4602-11.
6
7
A role for CD95 ligand in preventing graft rejection.CD95配体在预防移植排斥反应中的作用。
Nature. 1995 Oct 19;377(6550):630-2. doi: 10.1038/377630a0.
8
Involvement of the CD95 (APO-1/Fas) receptor and ligand system in Helicobacter pylori-induced gastric epithelial apoptosis.CD95（APO-1/Fas）受体和配体系统参与幽门螺杆菌诱导的胃上皮细胞凋亡。
J Clin Invest. 1998 Oct 15;102(8):1506-14. doi: 10.1172/JCI2808.
9
p53-mediated up-regulation of CD95 is not involved in genotoxic drug-induced apoptosis of human breast tumor cells.p53介导的CD95上调不参与基因毒性药物诱导的人乳腺肿瘤细胞凋亡。
Cell Death Differ. 1999 Mar;6(3):271-80. doi: 10.1038/sj.cdd.4400490.
10
CD95 ligand is a proliferative and antiapoptotic signal in quiescent hepatic stellate cells.CD95配体是静止肝星状细胞中的一种增殖和抗凋亡信号。
Gastroenterology. 2008 May;134(5):1494-506. doi: 10.1053/j.gastro.2008.02.021. Epub 2008 Feb 14.
引用本文的文献
1
Elevated TIM3 expression on bone marrow T cells drives immune dysfunction in early relapsed blood cancer after allogeneic hematopoietic stem cell transplantation.骨髓T细胞上TIM3表达升高会导致异基因造血干细胞移植后早期复发血癌的免疫功能障碍。
Exp Hematol Oncol. 2025 Aug 14;14(1):107. doi: 10.1186/s40164-025-00697-6.
2
CD95/Fas stoichiometry in future precision medicine.未来精准医学中的CD95/Fas化学计量学
Cell Death Differ. 2025 Apr 15. doi: 10.1038/s41418-025-01493-9.
3
Expanding the horizon of CAR T cell therapy: from cancer treatment to autoimmune diseases and beyond.拓展嵌合抗原受体T细胞疗法的视野：从癌症治疗到自身免疫性疾病及其他领域。
Front Immunol. 2025 Feb 19;16:1544532. doi: 10.3389/fimmu.2025.1544532. eCollection 2025.
4
Cervical Cancer Cells Use the CD95 and IL-2 Pathways to Promote Their Proliferation and Survival.宫颈癌细胞利用CD95和白细胞介素-2通路促进其增殖和存活。
Biomolecules. 2024 Dec 1;14(12):1543. doi: 10.3390/biom14121543.
5
The PRC2 complex epigenetically silences GATA4 to suppress cellular senescence and promote the progression of breast cancer.PRC2复合物通过表观遗传方式使GATA4沉默，以抑制细胞衰老并促进乳腺癌进展。
Transl Oncol. 2024 Aug;46:102014. doi: 10.1016/j.tranon.2024.102014. Epub 2024 Jun 5.
6
Strong apoptotic response of testis tumor cells following cisplatin treatment.顺铂治疗后睾丸肿瘤细胞出现强烈的凋亡反应。
Int Urol Nephrol. 2024 Mar;56(3):1007-1017. doi: 10.1007/s11255-023-03825-5. Epub 2023 Oct 27.
7
CD95/Fas ligand induced toxicity.CD95/Fas 配体诱导的毒性。
Biochem Soc Trans. 2023 Feb 27;51(1):21-29. doi: 10.1042/BST20211187.
8
Emerging roles of protein palmitoylation and its modifying enzymes in cancer cell signal transduction and cancer therapy.蛋白质棕榈酰化及其修饰酶在癌细胞信号转导和癌症治疗中的新兴作用。
Int J Biol Sci. 2022 May 9;18(8):3447-3457. doi: 10.7150/ijbs.72244. eCollection 2022.
9
Doxorubicin sensitizes breast cancer cells to natural killer cells in connection with increased Fas receptors.多柔比星通过增加 Fas 受体使乳腺癌细胞对自然杀伤细胞敏感。
Int J Mol Med. 2022 Mar;49(3). doi: 10.3892/ijmm.2022.5095. Epub 2022 Feb 4.
10
CD95/Fas protects triple negative breast cancer from anti-tumor activity of NK cells.CD95/Fas可保护三阴性乳腺癌细胞免受自然杀伤细胞的抗肿瘤活性影响。
iScience. 2021 Oct 29;24(11):103348. doi: 10.1016/j.isci.2021.103348. eCollection 2021 Nov 19.
Zotero 插件